CALR and neoplasm: Calreticulin (CRT) is an important initiator of this signaling; it contains tumor antigens (TAs) and tumor-associated antigens (TAAs) in dying cancer cells, and is exposed on the membrane surface and engulfed by immature and mature dendritic cells (DCs).